Santini V - Search Results

1

Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia.

Antonioli E, Guglielmelli P, Poli G, Bogani C, Pancrazzi A, Longo G, Ponziani V, Tozzi L, Pieri L, Santini V, Bosi A, Vannucchi AM; Myeloproliferative Disorders Research Consortium (MPD-RC). Antonioli E, et al. Among authors: santini v. Haematologica. 2008 Jan;93(1):41-8. doi: 10.3324/haematol.11653. Haematologica. 2008. PMID: 18166784 Free article.

2

[GM-CSF: its clinical administration; the treatment of aplasia].

Rossi Ferrini P, Grossi A, Santini V, Vannucchi AM. Rossi Ferrini P, et al. Among authors: santini v. Haematologica. 1989 Oct;74(5 Suppl):489-500. Haematologica. 1989. PMID: 2512231 Review. Italian. No abstract available.

3

Quantitation of bcl-2 oncogene in cultured lymphoma/leukemia cell lines and in primary leukemia B-cells by a highly sensitive RT-PCR method.

Quattrone A, Papucci L, Santini V, Schiavone N, Noferini D, Calastretti A, Copreni E, Morelli S, Rossi Ferrini PL, Nicolin A, et al. Quattrone A, et al. Among authors: santini v. Haematologica. 1995 Nov-Dec;80(6):495-504. Haematologica. 1995. PMID: 8647513

4

Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.

Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR. Santini V, et al. Haematologica. 1996 May-Jun;81(3):201-7. Haematologica. 1996. PMID: 8767524

5

Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.

Santini V, Bernabei A, Gozzini A, Scappini B, Zoccolante A, D'Ippolito G, Figuccia M, Ferrini PR. Santini V, et al. Haematologica. 1997 Jan-Feb;82(1):11-5. Haematologica. 1997. PMID: 9172997

6

Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.

Linari S, Vannucchi AM, Ciolli S, Leoni F, Caporale R, Grossi A, Pagliai G, Santini V, Paoletti F, Ferrini PR. Linari S, et al. Among authors: santini v. Br J Haematol. 1998 Sep;102(5):1335-7. doi: 10.1046/j.1365-2141.1998.00904.x. Br J Haematol. 1998. PMID: 9753066 Free article.

7

The potential of amifostine: from cytoprotectant to therapeutic agent.

Santini V, Giles FJ. Santini V, et al. Haematologica. 1999 Nov;84(11):1035-42. Haematologica. 1999. PMID: 10553165 Review.

8

Amifostine in the treatment of low-risk myelodysplastic syndromes.

Grossi A, Fabbri A, Santini V, Leoni F, Nozzoli C, Longo G, Pagliai G, Ciolli S, Rossi Ferrini P. Grossi A, et al. Among authors: santini v. Haematologica. 2000 Apr;85(4):367-71. Haematologica. 2000. PMID: 10756361 Clinical Trial.

9

Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647.

Santini V, Scappini B, Grossi A, Gozzini A, Bonsi L, Pagliai G, Rossi Ferrini P, Bagnara GP. Santini V, et al. Haematologica. 2002 Dec;87(12):1242-7. Haematologica. 2002. PMID: 12495897

10

Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance.

Ferrari G, Pastorelli R, Buchi F, Spinelli E, Gozzini A, Bosi A, Santini V. Ferrari G, et al. Among authors: santini v. J Proteome Res. 2007 Jan;6(1):367-75. doi: 10.1021/pr0603708. J Proteome Res. 2007. PMID: 17203980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page